GCC-Countries Organ Preservation Market Size, Share,Trends, Growth Analysis Report, 2030

Overview Request Sample Pages Request Customization Download PDF

You are viewing: GCC Countries Organ Preservation Market analysis

Part of: Organ Preservation Market (Global)

The GCC Countries Organ Preservation Market was valued at $24 Million in 2025 and projected to reach to $30.1 Million by 2030, representing a compound annual growth rate of 4.7%. The GCC organ preservation market is positioned for consistent growth through 2030, driven by regional healthcare modernization initiatives and increased transplant volumes.

GCC Countries Organ Preservation Market Trends and Insights

Roe's organ preservation sector is driven by advances in preservation technologies, increasing transplant demand, and improved healthcare infrastructure across the region.
The 4.7% compound annual growth rate reflects Roe's commitment to enhancing organ viability and transplant success rates through innovative preservation solutions. Roe's market dynamics are shaped by regulatory frameworks supporting transplantation programs and rising investment in cold chain logistics and perfusion systems.
Between 2025 and 2030, Roe is expected to see accelerated adoption of machine perfusion and hypothermic preservation technologies.
The region's focus on reducing organ discard rates and extending preservation windows positions Roe as a key market for organ preservation innovation in Europe..

Key Market Statistics

CAGR (2025-2030) 4.7% CAGR
Market Size, 2025 ~USD 24 Million
Forecast, 2030 ~USD 30.1 Million
Country GCC Countries

GCC Countries Organ Preservation Market Overview

Market Valuation :

The GCC organ preservation market is valued at $24.0 million in 2025, with a projected expansion to $30.1 million by 2030, representing a steady 4.7% CAGR.

Technology Advancement :

GCC countries are increasingly adopting advanced organ preservation technologies, including normothermic perfusion systems and improved cold storage solutions, enhancing transplant success rates.

Healthcare Infrastructure Growth :

Significant investments in healthcare infrastructure across UAE, Saudi Arabia, and Qatar are driving demand for sophisticated organ preservation systems and supporting transplant programs.

Transplant Demand Surge :

Rising prevalence of organ failure conditions and growing awareness of transplantation benefits in GCC nations are increasing demand for reliable organ preservation solutions.

GCC Countries Organ Preservation Market Dynamics

Countries like the UAE and Saudi Arabia are investing heavily in transplant infrastructure, creating opportunities for advanced preservation technologies.
The 4.7% CAGR reflects the region's measured but steady adoption of innovative solutions. Key growth drivers include improved regulatory frameworks, rising healthcare expenditure, and enhanced collaboration between GCC nations on transplant protocols.
As organ shortage remains a critical challenge, demand for preservation technologies that extend organ viability windows will continue to accelerate, supporting market expansion and attracting international medical device manufacturers to the region..

Related Ecosystem

Medical Devices

Top Technologies

Polymerase Chain Reaction (PCR)
Magnetic Resonance Imaging (MRI)
Disposable Autoinjectors
Pulse Oximeters
Blood Pressure Monitors

Top Companies

Medtronic plc
Abbott Laboratories
Stryker Corporation
Becton, Dickinson and Company
JOHNSON & JOHNSON

Key Takeaways

Roe's organ preservation market is valued at $24.0 million in 2025 and will grow to $30.1 million by 2030, representing a 4.7% CAGR.
Roe is investing heavily in machine perfusion and advanced hypothermic preservation technologies to improve transplant outcomes.
Regulatory support and healthcare infrastructure development in Roe are accelerating adoption of organ preservation solutions.
Roe's focus on reducing organ discard rates positions the region as a growing hub for preservation innovation in Europe.

Organ Preservation Market Report Scope

Report Metric	Details
Base Year	2025
Fastest Growing Segment	PERFADEX (Solution)
Forecast Period	2025�2030
Growth Rate	CAGR of 6.8% from 2025 to 2030
Largest Segment	ORGAN TRANSPLANT CENTERS (End User)
Market Size Base Year (Billions)	~USD 0.22 (2025)
Revenue Forecast (Billions)	~USD 0.3 (2030)
Segments Covered	Solution, Technique, Organ Type, End User

GCC Countries Organ Preservation Market Report Segmentation

4 segment dimensions are covered across the global market.

By Solution

Custodiol Htk
Other Solutions
Perfadex
University Of Wisconsin Solution

By Technique

Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Static Cold Storage

By Organ Type

Heart
Kidneys
Liver
Lungs
Other Organs

By End User

Hospitals
Organ Transplant Centers
Specialty Clinics

Target Audience

Medical Device Manufacturers : Evaluate market entry opportunities and expansion strategies in the GCC region's growing organ preservation technology sector.
Healthcare Investors : Assess investment potential in GCC transplant infrastructure and organ preservation solutions with detailed market forecasts and growth projections.
Hospital & Transplant Centers : Understand market trends, technology options, and procurement strategies for organ preservation systems across GCC healthcare facilities.
Government & Healthcare Policymakers : Develop informed policies and healthcare strategies based on comprehensive market data and regional transplant program requirements.
Consulting & Research Firms : Access detailed GCC market intelligence to support client advisory services, competitive analysis, and strategic recommendations in healthcare.

Key Companies in the GCC Countries Organ Preservation Market

Company	HQ	Ownership	Strongest segments
KINDRED HEALTHCARE INC.	United States	Private Company	Static Cold Storage�linked care (all solutions),Hypothermic machine perfusion�linked care,Normothermic perfusion�linked care,
XVIVO PERFUSION AB	Sweden	Public Company	Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions,
TRANSMEDICS, INC.	United States	Public Company	OCS Heart,OCS Lung,OCS Liver,
BIOLIFE SOLUTIONS, INC.	United States	Public Company	HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport),
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.	China	Private Company	UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms),

KINDRED HEALTHCARE INC.

Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.

XVIVO PERFUSION AB

XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.

TRANSMEDICS, INC.

TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.

BIOLIFE SOLUTIONS, INC.

BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.

SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.

Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.

Reasons to Buy this Report

Regional Market Insights : Gain detailed understanding of GCC-specific market dynamics, including country-level variations across UAE, Saudi Arabia, Qatar, Kuwait, Bahrain, and Oman.
Growth Opportunity Identification : Identify high-potential segments and emerging opportunities within the GCC region's 4.7% CAGR growth trajectory through 2030.
Competitive Landscape Analysis : Understand key players, market positioning, and competitive strategies specific to GCC healthcare systems and regulatory environments.
Investment Decision Support : Make informed investment and expansion decisions with comprehensive market sizing, forecasts, and trend analysis tailored to GCC market conditions.
Strategic Planning Data : Develop targeted go-to-market strategies and partnership approaches aligned with GCC healthcare infrastructure growth and transplant program expansion.

Frequently asked questions

What is the current size of the organ preservation market in Roe?

The organ preservation market in Roe was valued at $24.0 million in 2025 and is projected to reach $30.1 million by 2030.

What is the growth rate of Roe's organ preservation market?

Roe's organ preservation market is growing at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2030.

What technologies are driving growth in Roe's organ preservation sector?

Machine perfusion systems, hypothermic preservation technologies, and advanced cold chain logistics are the primary drivers of growth in Roe's organ preservation market.

How is Roe addressing organ discard rates?

Roe is implementing advanced preservation technologies and extending preservation windows to reduce organ discard rates and improve transplant success.

What regulatory factors support Roe's organ preservation market?

Roe has established regulatory frameworks supporting transplantation programs and healthcare infrastructure development that facilitate adoption of organ preservation solutions.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.

This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.

Primary Research

Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the organ preservation market includes the following details.

The market sizing was undertaken from the global side.

Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.

Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.

Market Definition

Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.

Stakeholders

Association of Organ Procurement Organizations (AOPO)
American Transplant Congress (ATC)
United Network for Organ Sharing (UNOS)
Network & Alliance of Transplant Coordinators (NATCO)
Consortium for Organ Preservation in Europe (COPE)
European Society for Organ Transplantation (ESOT)
Asian Society of Transplantation (AST)
National Health Service (UK NHS)
International Registry on Organ Donation and Transplantation (IRODaT)
Global Observatory on Donation and Transplants (GODT)
National Institutes of Health (NIH)
World Health Organization (WHO)
Organisation for Economic Co-operation and Development (OECD)
Centers for Disease Control and Prevention (CDC)
Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
White Papers, Journals/Magazines, and News Articles

Report Objectives

To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering

Get the Full Organ Preservation Market Report

Full forecast, segment splits, and company analysis for all Organ Preservation Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies